TR202021285A1 - Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon - Google Patents

Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon

Info

Publication number
TR202021285A1
TR202021285A1 TR2020/21285A TR202021285A TR202021285A1 TR 202021285 A1 TR202021285 A1 TR 202021285A1 TR 2020/21285 A TR2020/21285 A TR 2020/21285A TR 202021285 A TR202021285 A TR 202021285A TR 202021285 A1 TR202021285 A1 TR 202021285A1
Authority
TR
Turkey
Prior art keywords
borate
prevention
treatment
erbium
formulation
Prior art date
Application number
TR2020/21285A
Other languages
English (en)
Inventor
Şahi̇n Fi̇kretti̇n
Erhan Ayşan Mustafa
Nesli̇han Taşli Paki̇ze
Kaan Kirbaş Oğuz
Turhan Bozkurt Batuhan
Bülbül Berna
Original Assignee
Univ Yeditepe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yeditepe filed Critical Univ Yeditepe
Priority to TR2020/21285A priority Critical patent/TR202021285A1/tr
Priority to US18/268,997 priority patent/US20240050468A1/en
Priority to PCT/TR2021/051172 priority patent/WO2022139731A1/en
Priority to EP21911712.4A priority patent/EP4267244A1/en
Publication of TR202021285A1 publication Critical patent/TR202021285A1/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, yara skarının önlenmesi ve tedavisinde kullanılmak üzere, Erbium borat nanopartikülleri, en az bir yüzey aktif madde ve taşıyıcı jel özellikli en az bir jelleştirici madde içeren jel formunda bir formülasyon ile ilgilidir.

Description

TARIFNAME YARA SKARININ ÖNLENMESI VE TEDAVISINDE KULLANILMAK ÜZERE ERBIUM BORAT IÇEREN FORMÜLASYON Teknik Alan Bu bulus, yara skarinin önlenmesi ve tedavisinde kullanilmak üzere, erbiuin borat içeren, jel formunda farmasötik bir formülasyon ile ilgilidir. Önceki Teknik Cerrahi müdahale, travma, yanik ve Cilt enfeksiyonu gibi durumlar ile olusan yaralar, siklikla geride bir yara izi kalmasina sebep olmaktadir. Söz konusu yara izi teknik alanda skar olarak isimlendirilmekte olup, yara iyilesme sürecinin dogal bir sonucudur. Ancak, skar olusumu, yeni travmalara karsi dayaniksiz olmasinin yani sira agri ve kanama gibi istenmeyen durumlari da beraberinde getirmektedir. Skar olusumu ile ilgili en önemli görülen sorun ise kozmetik olarak kötü bir görünüme yol açmasidir. Yaralarda skar olusuinunu önlemek ve/veya olusmus skarlari tedavi etmek üzere, krem, merhem, pomat formunda birçok farmasötik ya da kozmetik ainaçli ürün gelistirilmistir. Söz konusu ürünlere ek olarak, çesitli cerrahi dikis teknikleri denenmis ancak ürünlerden ve söz konusu dikis tekniklerinden istenilen seviyede bir sonuç alinamamistir. Teknigin bilinen durumunda yer alan EP0770392 B1 sayili Avrupa patent basvurusu dokümaninda, aralarinda erbium tuzlarinin da bulundugu çesitli bilesenlerin tuzlarin, skar olusumuna karsi etkili farmasötik, kozmetik veya der'matolojik bir bilesim elde etmek üzere kullanimi açiklanmaktadir. Söz konusu bulusun tercih edilen bir uygulamasinda, bulusa konu olan bilesim; erbium tuzlarinin yani sira neodim klorür, glikolik asit, hidroksipropilselüloz, sodyum hidroksit, etanol ve koruyucu gibi ek bilesenler de içermektedir. Dokümanda, ayrica, bulus konusu ürünün jel formuna sahip olabilecegi belirtilmistir. 25418.109 teknik alandaki çözüm yöntemleri olarak bilinmektedir. Bulus ile Çözülen Sorunlar Bu bulusun amaci, yara skarinin önlenmesi ve tedavisinde kullanilmak üzere erbium borat içeren, jel formunda bir formülasyon gerçeklestirmektir. Bulus konusu jel formunda formülasyon, yara olustuktan sonra ortaya çikmasi muhtemel olan skarin olusumunu önleyerek, etkin bir kozmetik sonuç ortaya koyabilmektedir. Bulusun Ayrintili Açiklamasi Bulus konusu erbiyum borat temelli farmasötik formülasyon, yara skarinin önlenmesi ve tedavisinde kullanilmakta olup; etken bilesen olarak erbiyum borat nanopartikülleri ve en az bir yüzey aktif madde ve tasiyici jel özellikli en az bir jellestirici madde içermektedir. Bulusun bir uygulamasinda yüzey aktif madde olarak Plurononic F6& Pluronic F127 ve bunlarin karisimlarindan olusan bir gruptan seçilen en az bir yüzey aktif madde kullanilmaktadir. Bulusun bir uygulamasinda, j ellestiriei madde olarak Carbopol kullanilmaktadir. Bulusun bir uygulamasinda, farmasötik formülasyon, kütlece % 0,5-10 Pluronic 0,1-10 Sodyum pentaborat içermektedir. 25418.109 Bulusun farkli bir uygulamasinda, farmasötik formülasyon, kütlece % 0,5-10 NP, % 0,1-10 NaOl-l, % 0,01-10 Chlorhexidine içermektedir. Bulus konusu farmsötik bilesim, yara olustuktan sonra ortaya çikmasi muhtemel olan skarin olusumunu önleyerek, etkin bir kozmetik sonuç ortaya koyabilmektedir. Bulusun gelistirilmesi süresinde gerçeklestirilen deneysel çalismalardan, in vitro çalisinalarda erbium borat temelli formülasyonun yara skari olusumunda temel eleman olan kollajen l türevi yerine yara izi birakmadan iyilesme ile karakterize olan kollagen 3 türevinin ve tibromodulin ifadeleri arttigi gözlemlenmektedir. Ek olarak yara skari formasyonunun ortadan kaldirilmasinda oldukça önemli olan matriks metalloproteaz protein 9 enziminin aktivitesinin arttigi belirlenmistir. Ayrica siçanlar üzerinde yapilan in vi'vo çalismada kontrol grubu ile karsilastirildiginda erbium borat temelli formülasyonun daha az yara skari TR TR TR

Claims (1)

1.ISTEMLER . Yara skarinin önlenmesi ve tedavisinde kullanilmak üzere, - Erbium borat nanoparrikülleri, - En az bir yüzey aktif madde ve - Tasiyici jel özellikli en az bir jellestirici madde içermesi ile karakterize edilen jel formunda bir formülasyon. . Yüzey aktif madde olarak Pluronic F68 ve/veya Pluronic F127 içermesi ile karakterize edilen Istem 1”deki gibi bir formülasyon. . J ellestirici madde olarak Carbopol içermesi ile karakterize edilen Istem 1 veya karakterize edilen lstem l”deki gibi bir formülasyon. içermesi ile karakterize edilen Istem 1”deki gibi bir formülasyon. TR TR TR
TR2020/21285A 2020-12-22 2020-12-22 Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon TR202021285A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2020/21285A TR202021285A1 (tr) 2020-12-22 2020-12-22 Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon
US18/268,997 US20240050468A1 (en) 2020-12-22 2021-11-09 Formulation comprising erbium borate for use in prevention and treatment of wound scars
PCT/TR2021/051172 WO2022139731A1 (en) 2020-12-22 2021-11-09 Formulation comprising erbium borate for use in prevention and treatment of wound scars
EP21911712.4A EP4267244A1 (en) 2020-12-22 2021-11-09 Formulation comprising erbium borate for use in prevention and treatment of wound scars

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2020/21285A TR202021285A1 (tr) 2020-12-22 2020-12-22 Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon

Publications (1)

Publication Number Publication Date
TR202021285A1 true TR202021285A1 (tr) 2022-07-21

Family

ID=82160041

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2020/21285A TR202021285A1 (tr) 2020-12-22 2020-12-22 Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon

Country Status (4)

Country Link
US (1) US20240050468A1 (tr)
EP (1) EP4267244A1 (tr)
TR (1) TR202021285A1 (tr)
WO (1) WO2022139731A1 (tr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010270723A1 (en) * 2009-07-06 2012-02-09 Molycorp Minerals Llc Ceria for use as an antimicrobial barrier and disinfectant in a wound dressing
WO2014168595A1 (en) * 2013-04-08 2014-10-16 Yeditepe Universitesi Polymer based hydrogel
WO2020091699A1 (en) * 2018-10-31 2020-05-07 Yeditepe Universitesi Use of nano-sized lanthanide borate (dysprosium borate and erbium borate) compounds for wound healing purposes and production method thereof

Also Published As

Publication number Publication date
EP4267244A1 (en) 2023-11-01
US20240050468A1 (en) 2024-02-15
WO2022139731A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
desJardins-Park et al. The spectrum of scarring in craniofacial wound repair
JP5848260B2 (ja) スキンケアでの利用のための安定化プロテアーゼ
US9468779B2 (en) Viscoelastic gel for dermatological use
JPS6323166B2 (tr)
RU2673342C2 (ru) Способы и композиции для улучшения внешнего вида и формирования рубцовой ткани
JP7193662B2 (ja) ペプチド成分の皮膚再生および治癒混合物とその使用
US20180360712A1 (en) Cosmetic composition and use thereof
US20170182069A1 (en) Topically applicable chemical peel composition
JP2024014923A (ja) 瘢痕を最小化することにおける使用のための神経毒
KR20150128481A (ko) 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물
CZ178196A3 (en) Pharmaceutical preparation for papulopustular punctual therapy
WO2014190179A2 (en) Urea silicon gel for scars and hydration treatment and method of using same
EP3087993B1 (en) Pharmaceutical composition comprising acetyl hexapeptide-8 and pentapeptide-18 for treating anal fissures
TR202021285A1 (tr) Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon
RU2404745C2 (ru) Гидрофильная фармацевтическая композиция для лечения ожогов (варианты)
KR20210063600A (ko) 피부개선 효과를 갖는 동결건조 패치형 화장료조성물
US9125892B2 (en) Composition for reduced scar formation of wounds
TW201632191A (zh) 一種用於促進傷口癒合或預防、減少傷口疤痕生成的醫藥組合物
KR20220087501A (ko) 박테리아 감염 및 상처 치유를 위한 약제학적 조성물을 함유하는 국소 항생제
CN113855595A (zh) 一种具备生物活性的抗衰老冻干粉制剂
CN116528846A (zh) 用于皮肤和粘膜的创伤性损伤愈合的制剂
WO2013122994A1 (en) Skin care product
CN113413331A (zh) 祛痘组合物及其制剂和用途
Namviriyachote et al. Sulfadiazine Cream Treatment of Chemical Burn with Topical Silver Zinc Sericin Sulfadiazine Cream
US20100255070A1 (en) Compositions and methods for preventing, minimizing and healing skin irritation and trauma